ClinicalTrials.gg
Status unknownNCT03482674DiminiUpdated Apr 6, 2018

DIMINI - Diabetes Mellitus? - Not me!

An interventional study of DIMINI lifestyle intervention in Health Behavior, Health Knowledge, Attitudes, Practice and Literacy, sponsored by Dimini Konsortium. Status unknown at 1 site in Germany. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-04-06.

Sponsored by Dimini Konsortium · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2018), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
530
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The increasing prevalence of type 2 diabetes mellitus is a worldwide problem. In preventing risk factors and unhealthy lifestyle through improved health literacy, chances are seen to delay or even avoid type 2 diabetes mellitus. The aim of the DIMINI-project is to prevent type 2 diabetes mellitus and to strengthen the health literacy of people at increased risk of developing it. For this purpose, people at increased risk are first identified by using the standardized screening tool Finnish Diabetes Risk Score (FINDRISC) adapted for Germany. Identified risk persons then receive a needs-based, modular lifestyle intervention including nutrition tips and physical exercises either paper- or app-based.

Read the detailed description

DIMINI, a randomised controlled trial, will assess whether the implementation of a lifestyle intervention for people at increased risk of developing type 2 diabetes mellitus will result in an improvement in body weight (primary outcome) and participants health literacy (secondary outcome) or not. A three-month intervention in the intervention group is followed by a one-year follow-up. The control group receives standard care as provided by the German statutory health insurance for three months and a one-year follow-up as well.

02

Conditions studied

  • Health Behavior
  • Health Knowledge, Attitudes, Practice
  • Literacy
  • Diabetes Mellitus, Type 2
  • Diabetes

Keywords

  • Health literacy
  • Innovation Fund
  • lifestyle intervention
  • risk screening
  • type 2 diabetes mellitus
  • Diabetes Mellitus, Type 2
03

In context

Health Behavior

967 studies on the registry are indexed under Health Behavior; 165 are open to participants now.

This study's planned enrollment of 530 is above the median of 150 across 824 interventional studies indexed under Health Behavior.

Browse Health Behavior studies →

Lead sponsor

This is the only study on the registry with Dimini Konsortium as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age ≥ 18 years
  • resident in Hesse or Schleswig-Holstein
  • statutory health insurance in one out of five participating health insurances
  • overweight/obesity
  • low physical activity
  • known family disposition for type 2 diabetes mellitus
  • history of increased glucose levels
  • FINDRISC results with scores ≥ 12

Exclusion criteria

Exclusion Criteria:

  • age \< 18 years
  • resident outside Hesse or Schleswig-Holstein
  • statutory or private health insurance with other than the participating health insurances
  • clinically manifested diabetes mellitus
  • malnutrition
  • psychiatric disorders
  • pregnancy
  • FINDRISC results with scores \<12
  • participation in other clinical trials
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
530 participants (estimated)

Study arms

  • No intervention
    Control Group

    The control group will receive standard care as provided by the German statutory health insurance.

  • Experimental
    Intervention group

    The intervention group receives the DIMINI lifestyle intervention for a period of three months.

    Behavioral: DIMINI lifestyle intervention

Interventions

  • BehavioralDIMINI lifestyle intervention

    DIMINI lifestyle intervention consists of the DIMINI-kit which contains health information, a list of food recommendations with additional information on calories, serving size and weight (traffic light rating system), a nutrition and an exercise diary. Participants in the intervention group can choose between a paper-based version or an app-based version of the DIMINI-kit. In addition, the kit includes an elastic exercise band with exercise poster, a measuring tape for self-control of the waist size and a pedometer.

06

What researchers measure

Primary outcomes

  1. Body weight reduction

    Survey of weight general practitioners level

    Time frame: 15 Months

Secondary outcomes

  1. Health literacy (European Health Literacy Survey Questionnaire)

    Summed scale: * Maximum: 16 (best health literacy) * Minimum: 0 (worst health literacy) * ≥ 13 = sufficient health literacy * 9-12 = problematic health literacy * ≤ 8 = inadequate health literacy Higher values represent a better outcome

    Time frame: 15 Months

  2. Eating behaviour (German questionnaire on eating behaviour)

    Three summed subscales: Scale 1) cognitive control of eating behavior, restrained eating * Minimum score: 0 = no cognitive control * Maximum score: 21 = extreme cognitive control Scale 2) disturbance of eating behavior * Minimum score: 0 = no disturbance * Maximum score: 16 = extreme disturbance Scale 3) experienced feelings of hunger * Minimum score: 0 = no disturbing sensations of hunger * Maximum score: 14 = very strong disturbing sensations of hunger For each item it is determined individually, which response option is considered to get a value of 1 or a value of 0 (e.g. Scale 1 Item 12: "true" = 1, "not true" = 0, Item 18 "true" = 0, "not true" = 1)

    Time frame: 15 Months

  3. Physical activity (International Physical Activity Questionnaire)

    Questionnaire designed for population surveillance of physical activity among adults including Total Score: * Maximum Score: 960 minutes * Minimum Score: 10 minutes Categorical Score: Category 1 - Low: • Individuals who not meet criteria for Categories 2 or 3 Category 2 - Moderate: * 3 or more days of vigorous-intensity activity of at least 20 minutes per day * 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day * 5 or more days of any combination of walking, moderate-intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 minutes/week. Category 3 High * vigorous-intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 minutes/week * 7 or more days of any combination of walking, moderate-intensity or vigorous-intensity activities achieving a minimum total physical activity of at least 3000 minutes/week.

    Time frame: 15 Months

  4. Quality of life

    Short Form 12

    Time frame: 15 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Puschner F, Wetzel S, Urbanski-Rini D, Bertram N, Schliffke M, Gohl M, Petersen C; Dimini Consortium. The association between the risk of developing type 2 diabetes mellitus and health-related quality of life: baseline results from the Dimini lifestyle intervention. Qual Life Res. 2021 Dec;30(12):3523-3533. doi: 10.1007/s11136-021-02878-2. Epub 2021 May 19. PubMed 34008163 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2018 (actual). Primary completion is estimated for Mar 2020, 26 months after the start.

Of 567 non-industry interventional studies with no phase under Health Behavior, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 33. This study's planned 26 months is above that.

Counting every sponsor, half of 585 studies reached it within 15 months; a quarter within 5 and three quarters within 32.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 6, 2018
First posted
Mar 29, 2018
StartActual
Jan 2, 2018
Primary completionEst.
Mar 31, 2020
CompletionEst.
Jul 1, 2020
Last update
Apr 6, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 6, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03482674
Lead sponsor
Dimini Konsortium
Collaborators
Deutsche Diabetes Gesellschaft
Responsible party
Sponsor
First posted
Mar 29, 2018
Start date
Jan 2, 2018
Primary completion
Mar 31, 2020 (estimated)
Completion
Jul 1, 2020 (estimated)
Last update
Apr 6, 2018

Study contacts

Carsten Petersen, Dr.
Contact
c.petersen@internisten-schleswig.de
+494621-855 425
Volker E Amelung, Prof. Dr.
Contact
info@inav-berlin.de
+4930-24631222
Carsten Petersen, Dr.
principal investigator · docevent GmbH

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion